Copenhagen, Denmark, 29 June 2026 – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company maximizing surgical outcomes in oncology by lighting up

The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.

The Reuters Daily Briefing newsletter provides all the news you need to start your day.